Wegovy (semaglutide subcutaneous solution), Duobrii (halobetasol propionate/tazarotene lotion) and Radicava ORS (edaravone oral suspension) are among the brands covered by new product-specific guidances for generic development that have just been issued by the US Food and Drug Administration.
The FDA publishes PSGs to help facilitate generic drug development by providing recommendations for developing generic drugs and generating evidence...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?